# Cytogenetic and molecular diagnosis of Fanconi anemia revealed two hidden phenotypes: Disorder of sex development and cerebro-oculo-facio-skeletal syndrome

Abir Ben Haj Ali, Ahlem Amouri, Marwa Sayeb, Saloua Makni, Wajih Hammami, Chokri Naouali, Hamza Dallali, Lilia Romdhane, Anu Bashamboo,

Ken Mcelreavey, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Abir Ben Haj Ali, Ahlem Amouri, Marwa Sayeb, Saloua Makni, Wajih Hammami, et al.. Cytogenetic and molecular diagnosis of Fanconi anemia revealed two hidden phenotypes: Disorder of sex development and cerebro-oculo-facio-skeletal syndrome. Molecular Genetics & Genomic Medicine, 2019, 7 (7), pp.e00694. 10.1002/mgg3.694. pasteur-03263632

HAL Id: pasteur-03263632

https://pasteur.hal.science/pasteur-03263632

Submitted on 17 Jun 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
ORIGINAL ARTICLE

<figure><img src="image_3.png" /></figure>

WILEY

# Cytogenetic and molecular diagnosis of Fanconi anemia revealed two hidden phenotypes: Disorder of sex development and cerebro-oculo-facio-skeletal syndrome

Abir Ben Haj Ali<fnref n="1" />,<fnref n="2" />

Ahlem Amouri<fnref n="1" />,<fnref n="2" />

Marwa Sayeb<fnref n="2" />

Saloua Makni<fnref n="3" />

Wajih Hammami<fnref n="1" />,<fnref n="2" />

Chokri Naouali<fnref n="2" />

Hamza Dallali<fnref n="2" />

Lilia Romdhane<fnref n="2" />

Anu Bashamboo<fnref n="4" />

Kenneth McElreavey<fnref n="4" />

Sonia Abdelhak<fnref n="2" />

Olfa Messaoud<fnref n="2" />

**Correspondence**

Olfa Messaoud, Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, University Tunis El Manar, Tunis, Tunisia.
Email address: olfa.messaoud@pasteur.tn

**Funding information**

FP7 Coordination of Non-Community Research Programmes, Grant/Award Number: 295097; Tunisian Ministry of Higher Education and Scientific Research, Grant/Award Number: LR16IPT05

**Abstract**

**Background:** Several studies have shown a high rate of consanguinity and endogamy in North African populations. As a result, the frequency of autosomal recessive diseases is relatively high in the region with the co-occurrence of two or more diseases.

**Methods:** We report here on a consanguineous Libyan family whose child was initially diagnosed as presenting Fanconi anemia (FA) with uncommon skeletal deformities. The chromosome breakage test has been performed using mitomycin C (MMC) while molecular analysis was performed by a combined approach of linkage analysis and whole exome sequencing.

**Results:** Cytogenetic analyses showed that the karyotype of the female patient is 46,XY suggesting the diagnosis of a disorder of sex development (DSD). By looking at the genetic etiology of FA and DSD, we have identified p.[Arg798*];[Arg798*] mutation in FANCJ (OMIM #605882) gene responsible for FA and p.[Arg108*];[Arg1497Trp] in EFCAB6 (Gene #64800) gene responsible for DSD. In addition, we have incidentally discovered a novel mutation p.[Gly1372Arg];[Gly1372Arg] in the ERCC6 (CSB) (OMIM #609413) gene responsible for COFS that might explain the atypical severe skeletal deformities.

**Conclusion:** The co-occurrence of clinical and overlapping genetic heterogeneous entities should be taken into consideration for better molecular and genetic counseling.

**KEYWORDS**

autozygosity mapping, Comorbidity, genetic counseling, incidental findings, whole exome sequencing

1 | INTRODUCTION

North African populations are characterized by their heterogeneous ethnic background and high rate of inbreeding.

The consanguinity rate is influenced by several factors including demographic, religious, cultural, and socioeconomic conditions (Romdhane & Abdelhak, 2011). The high rate of consanguinity has been usually associated with

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

© 2019 The Authors. *Molecular Genetics & Genomic Medicine* published by Wiley Periodicals, Inc.

<footnote n="1">¹Laboratory of Histology and Cytogenetics, Institut Pasteur de Tunis, University Tunis El Manar, Tunis, Tunisia</footnote>

<footnote n="2">²Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, University Tunis El Manar, Tunis, Tunisia</footnote>

<footnote n="3">³Children's Hospital of Tunis, Tunis, Tunisia</footnote>

<footnote n="4">⁴Human Developmental Genetics, Institut Pasteur de Paris, Paris, France</footnote>
the emergence of autosomal recessive diseases at high fre-
quencies (Teebi, 1994). In fact, it was reported that among
346 genetic disorders described in Tunisia, 62.9% are au-
tosomal recessive (Romdhane & Abdelhak, 2011). Fanconi
anemia (FA) is among the diseases for which incidence
is increased by consanguinity (Hadiji et al., 2012), hence
allowing founder ancestral mutations such as exon 15 de-
letion in FANCA (OMIM #607139) gene to be frequently
observed (Amouri et al., 2014). Indeed, more than 142 pa-
tients with a consanguinity rate of 86% have been registered
in the Tunisian Fanconi Anemia Registry (TFAR) (Hadiji
et al., 2012). As the Tunisian population structure is very
similar to that of neighboring countries, FA prevalence is
expected to be just as high in these countries. In Egypt,
among 48 patients clinically suspected to have FA, the di-
agnosis has been cytogenetically confirmed for 31 cases for
whom the consanguinity rate reaches 97% (Temtamy et al.,
2007). Jewish FA patients have been reported mostly from
Morocco and Tunisia (Tamary et al., 2000). In Libya, the
consanguinity rate reaches 37.6% in Benghazi (Abudejaja
et al., 1987). Unfortunately, epidemiological studies for nu-
merous cases including FA are lacking due to an unstruc-
tured health system.

FA is a rare genetic disease characterized by variable con-
genital defects, hematological problems, and cancer. A large
clinical heterogeneity is associated with this syndrome. Indeed,
the clinical manifestation differs from one patient to another
and it is due to several factors that remain unknown. As the
biological diagnosis of FA relies on double-stranded DNA
breaks in the chromosomes of FA patients when cultured with
DNA interstrand cross-linking agents, such as diepoxybutane
(DEB) (Auerbach, 2003) or mitomycin C (MMC) (Cervenka,
Arthur, & Yasis, 1981), all FA genes are known to play a role
in double-stranded DNA (dsDNA) breaks repair. In the ab-
sence of a clear phenotype–genotype correlation, molecular
diagnosis of FA is complicated. Until now, 21 responsible FA
genes have been defined (Mamrak, Shimamura, & Howlett,
2017). The gravity of this disease justifies an adequate genetic
counselling and prenatal or preimplantation genetic diagno-
sis, which requires precise identification of the pathogenic
mutations.

Here, we report on a Libyan FA child who was addressed
with a suspicion of FA but further investigations showed co-
occurrence of three different rare genetic and clinical entities.

**2 | PATIENTS AND METHODS**

**2.1 | Ethical compliance**

This study was conducted in accordance with the declaration
of Helsinki and the ethical standards of the Institut Pasteur
de Tunis Institutional Review Board (Registration number

IRB00005445, FWA00010074). Informed consent of the
legal representatives of the patient was obtained.

**2.2 | Clinical and genealogical description**

A female patient S156-V-2, aged 4 years and born to young healthy second-degree cousins was addressed to our department in Institut Pasteur de Tunis (IPT) for FA cytogenetic test (Figure1a). Physical examination revealed: growth retardation, microcephaly, facial dysmorphism, beaked nose, thin lips, upper lip overhanging the lower one, café au lait spots, and severe skeletal deformities including bilateral radial agenesis with absent thumbs (Figure1b). The eldest sister V-1 was healthy. The mother had a history of two additional pregnancies, the first resulted in a spontaneous miscarriage while the second was marked by aneonatal death due to congenital malformations mainly marked by severe polydactyly; however, no cytogenetic nor molecular studies have been performed.

**2.3 | Chromosomal breakage test**

A standard chromosomal breakage test with MMC in peripheral blood cultures has been conducted to assess chromosomal hypersensitivity to clastogenic agents as previously detailed (Talmoudi et al., 2013).

**2.4 | Genetic analysis**

After obtaining a written consent from the parents, EDTA-blood
samples were received and genomic DNA was extracted apply-
ing the standard salting-out method (Miller, Dykes, & Polesky,
1988). Whole exome sequencing (WES) was performed using
5 µg of the genomic DNA sample. Sanger sequencing was car-
ried out to confirm the mutations identified by WES. All PCR
products were directly sequenced on an ABI 3,130 automated
sequencing system (Applied Biosystems, CA). Sequences
were then compared to published sequences of the FANCIgene
(NM_032043.2), EFCAB6 gene (NM_022785.4), and ERCC6
gene (NM_000124.4) using the Sequencher 5.0 software pro-
gram package (Gene Codes, MI, and USA).

**2.4.1 | Prescreening of exon 15 deletion in**
**FANCA gene**

The *FANCA* gene is the most frequent gene being responsible
of almost 90% of FA in Tunisian (Bouchlaka et al., 2003),
Algerian, and Libyan patients (unpublished data); thus the
patient reported here was initially screened using a PCR-
based approach for exon 15 deletion in *FANCA* gene which
is a common founder mutation in Southern Tunisia (Amouri
et al., 2014) and among patients from Libya and Algeria (un-
published data).
<figure><img src="image_4.png" /><figcaption>**FIGURE 1** (a) Pedigree of the Libyan FA family; arrows indicate the members with available DNA. (b) Phenotypical features of S156-V-2 patient</figcaption></figure>

## 2.4.2 | Homozygosity mapping

Taking into account the recessive trait of FA and the consanguinity of the index case, we applied homozygosity mapping strategy to look for regions of homozygosity by descent and consequently locate the responsible gene(s) with the causative mutation(s). Whole exome Single Nucleotide Polymorphism (SNP) genotype data from the index case and her parents were analyzed for the presence of runs of homozygosity (McQuillan et al., 2008) through the Runs of Homozygosity (ROH) tool from PLINK v1.06 (http://pngu.mgh.harvard.edu/purcell/plink). We kept the default settings of the “homozygous” command. Then, we applied the FSuite software for better visualization and determination of these ROHs (Gazal, 2014).

## 2.4.3 | Whole exome sequencing

In order to define disease-relevant variants, we realized WES for the index case S156-V-2 and her parents. WES and bioinformatics' analysis were performed by Oxford Gene Technology (OGT; London, UK). Briefly, samples were prepared according to Agilent's SureSelect Protocol Version 1.2 (Agilent Technologies; Santa Clara, CA). Obtained libraries were pooled prior to sequencing with each sample at a final concentration of 10nM. Paired-end sequencing was performed on the Illumina HiSeq2000 platform using TruSeq v3 chemistry. Read files (Fastq format) were generated from the sequencing platform via the manufacturer's proprietary software. Burrows-Wheeler Aligner's sample algorithm, for paired-end-short read alignment (BWA-short version 0.6.2) (Li & Durbin., 2009), was used for mapping to the human genome (hg19/b37). Sequence alignment Map (SAM) was

converted to Binary Alignment Map (BAM) using Sam tools version 0.1.18. (Li et al., 2009). Further BAM files processing was performed using Picard tools version 1.89 (http://broadinstitute.github.io/picard) and Genome Analysis Tool Kit (GATK) version 1.6 (https://software.broadinstitute.org/gatk/documentation/version-history.php) (McKenna et al., 2010), which was also used for variant calling and variant filtering. Single nucleotide polymorphism (SNP) novelty was determined against dbSNP137. Candidate variants were analyzed by a range of web-based bioinformatic tools like the Ensembl SNP Effect Predictor (https://www.ensembl.org/info/docs/tools/vep/index.html) (McLaren et al., 2016) and VarioWatch (http://grch37.genepipe.ncgm.sinica.edu.tw/variowatch/main.do) (Cheng et al., 2012). All variants were screened against the Human Gene Mutation Database Public version (Biobase) (http://www.hgmd.cf.ac.uk/ac/index.php) (Stenson et al., 2003). In silico analysis was done to evaluate the likely pathogenicity of variants using PolyPhen (http://genetics.bwh.harvard.edu/pph2/) (Sunyaev et al., 2001), SIFT (https://sift.bii.a-star.edu.sg/) (Ng & Henikoff, 2003), Align-GVGD (http://agvgd.iarc.fr/) (Tavtigian et al., 2006), Pmut (http://mmb2.pcb.ub.es/PMut/) (Ferrer-Costa et al., 2005), and Fruitfly (http://www.fruitfly.org/seq_tools/splice.html) (Reese, Eeckman, Kulp, & Haussler, 1997) for splice-site predictions.

# 3 | RESULTS

In our study, we investigated at clinical, cytogenetic, and molecular levels a patient with a suspicion of FA. The cytogenetic instability assessment revealed a high frequency of chromosomal breakages (8.64 breaks/cell) compared to control (0.062
<figure><img src="image_5.png" /></figure>

**FIGURE 2** (a) Metaphase spread from the patient S156-V-2, after exposure to Mitomycin C (MMC), exhibiting multiple chromosomal breaks and radial formations that are indicated by arrows. (b) Constitutional karyotype 46,XY of the patient S156-V-2

<figure><img src="image_6.png" /></figure>

**FIGURE 3** Circular representation of autosomal chromosomes indicating regions of homozygosity (ROH) drawn from WES data of the Libyan family using FSuite software (from outside to inside: IV-1, IV-2 and S156-V-2). Overlapping of the father's, the mother's, and the patient's ROH map showed that only two ROH (in rectangular boxes) are identical by descent

breaks/cell) (Figure 2a). In addition to clinical features, these results confirmed the diagnosis of FA. The karyotype analysis and the standard chromosomal breakage test showed 46,XY in all analyzed mitoses. The father IV-1 and the mother IV-2 had both a normal karyotype (46,XY; 46,XX, respectively). This incidental discovery is suggesting sex reversion (Figure 2b).

After excluding exon 15 deletion in *FANCA* gene, WES data analysis allowed identification of a nonsense mutation c.[2392C>T];[2392C>T]: p.[Arg798*];[Arg798*] at homozygous state in exon 17 of *BRIP1/FANCI* gene which is responsible for FA. Homozygosity mapping showed the presence of two IBD-ROH (Identity by descent-Runs of

homozygosity) (Figure 3). The first one is located in chromosome 17 and contains the *BRIP1/FANCI* gene, thus supporting the involvement of the identified mutation in the FA phenotype. The second ROH is located in chromosome 10 and includes the *ERCC6* gene. By filtering pathogenic variants from WES data, we identified a novel missense mutation c.[4114G>A];[4114G>A]: p.[Gly1372Arg];[Gly1372Arg] at homozygous state occurring in exon 21 of *ERCC6* which is the major gene underlying cerebro-oculo-facio-skeletal (COFS) syndrome. By analyzing 37 genes reported as being involved in DSD (Kyriakou, Lucas-Herald, McGowan, Tobias, & Ahmed, 2015) and the genes they
<figure><img src="image_7.png" /><figcaption>**FIGURE 4** Sequencing results of the proband S156-V-2 and her parents (IV-1, IV-2): (a) a nonsense mutation c.[2392C>];[2392C>T]: p.[Arg798*];[Arg798*] in exon 17 of *BRIP1/FANCJ*; (b) a nonsense mutation c.[322C>T]: p.[Arg108*] in exon 4 of *EFCAB6* gene; (c) a missense mutation c.[4489C>T]: p.[Arg1497Trp] in exon 32 of *EFCAB6* gene and (d) a missense mutation c.[4114G>A];[4114G>A]: p.[Gly1372Arg];[Gly1372Arg] in exon 21 of *ERCC6* gene</figcaption></figure>

interact with, a novel compound heterozygous mutation in *EFCAB6* gene, a nonsense and a missense mutations c.[322C>T];[4489C>T]: p.[Arg108*];[Arg1497Trp] affecting respectively exon 4 and exon 32 were identified. Sanger sequencing confirmed the segregation of all the variants identified above by the analysis of parents samples (Figure 4). In fact, the nonsense mutation has been inherited from the mother while the missense mutation has been inherited from the father. Thus, these results confirmed that the two compound heterozygous variants are in trans.

4 | DISCUSSION

We report a rare case of comorbidity involving three rare autosomal recessive diseases namely, FA, DSD, and COFS, affecting the same individual. Genetic analysis, using homozygosity mapping and WES, showed that patient S156-V-2 is carrying a nonsense mutation, p.[Arg798*];[Arg798*] in *BRIP1/FANCJ* gene, causing FA, a compound heterozygous mutation in *EFCAB6* gene, p.[Arg108*];[Arg1497Trp] causing DSD

and a missense mutation, p.[Gly1372Arg];[Gly1372Arg] in *ERCC6* gene responsible for COFS syndrome.

BRIP1 (BRCA1 Interacting Protein C-Terminal Helicase 1), is a Fanconi anemia gene (*FANCJ*) (Litman et al., 2005) that functions in DNA damage repair (Bridge, Vandenberg, Franklin, & Hiom, 2005; Litman et al., 2005).

Homozygous mutations in *BRIP1/FANCJ* result in FA phenotype (Kumaraswamy & Shiekhattar, 2007), while heterozygous truncating mutations are associated with a moderate risk of breast cancer (Levran et al., 2005; Seal et al., 2006; Walsh & King, 2007).

The most widespread pathogenic mutation identified in *BRIP1/FANCJ* is p.[Arg798*]. This mutation has been initially described in 2005 to be associated with a lack of BRIP1 expression and hence a deficiency of double-stranded DNA breaks repair by homologous recombination (Levitus et al., 2005; Levran et al., 2005; Litman et al., 2005). This truncating mutation has been found in patients presenting a severe aplastic anemia from diverse populations, suggesting that it is either a relatively ancient founder mutation or a recurrent one (Levitus et al., 2005; Seal et al., 2006). The p.[Arg798*] mutation is common in Saudi FA patients (40% of all FA patients), compared to only 2% among FA European patients (Ghazwani et al., 2016; Levitus et al., 2005). It is notable that our patient presents more severe skeletal deformities than all previously described patients having this mutation, suggesting that they might result from the mutation identified in the *ERCC6* gene (ERCC excision repair 6, chromatin remodeling factor) which is involved in transcription-coupled excision repair (Meira et al., 2000). All mutations identified in this gene are associated with Cockayne syndrome type B and COFS syndrome. COFS is a rare autosomal recessive disorder characterized by microcephaly, cataract, microphthalmia, distinctive facial dysmorphism and arthrogryposis (Lowry, MacLean, McLean, & Tischler, 1971; Preus & Fraser, 1974). This disorder is genetically heterogeneous and, at present, four different genes called excision repair cross-complementing genes (*ERCC6*, *ERCC2*, *ERCC5*, and *ERCC1*) are responsible for this phenotype (Jaakkola et al., 2010). Here, we report a novel mutation in *ERCC6* gene that might explain all or at least a part of the facial dysmorphism and skeletal malformations observed in our patient. Interestingly, such complex overlapping features including FA and other DNA-repair disorders were described in a recent study that reported a malfunction of the nuclease *ERCC1-ERCC4* (XPF) resulting in complex clinical manifestations comprising *Xeroderma pigmentosum* (XP), Cockayne syndrome (CS), and Fanconi anemia (FA) (Kashiyama et al., 2013). In another study, mutations in *ERCC4* were described to be involved in FA but without the features of CS and XP (Bogliolo et al., 2013). Before Kashiyama's report of the *ERCC1* mutant patient with COFS syndrome, Jaspers et al. (2007) had reported a first case of *ERCC1* F231L mutation with mild NER deficiency,
<figure><img src="image_8.png" /><figcaption>**FIGURE 5** Strategy of cytogenetic and molecular investigation</figcaption></figure>

heterogeneous congenital COFS syndrome, and severe pre-
and postnatal growth failure. This was followed by charac-
terization of the loss of *ERCC1-XPF* optimal interaction by
Faridounnia et al. (2015). COFS syndrome has been mainly
reported to be linked to *CSB*, *XPD*, or *XPG* mutations (Drury
et al., 2014; Laugel et al., 2010; Nouspikel, 2009; Powell,
Meira, & Friedberg, 2000). Taken together, these findings
demonstrate that defects occur in both of *ERCC4* and *ERCC1*
can result in either CS or the combined XP-CS-FA pheno-
type (Kashiyama et al., 2013). In this regard, the question that
arises is that whether the severe skeletal abnormalities result
from the *FANCI* or *ERCC6* mutation. More pronounced skel-
etal deformities observed in our patient supports the involve-
ment of the *ERCC6* mutation. Furthermore, the predicted
result from in silico tools (SIFT = 0.005, Varsome = 0.9994,
MutationTaster = 1) showed that the pathogenic effect for the
*ERCC6* mutation is the second hypothesis.

Despite being consanguineous, the patient S156-V-2 has
two novel deleterious mutations at compound heterozygous
state that are responsible for sex reversion. DSD diseases are
known to be clinically very heterogeneous. Thus, a careful
neonatal exam is crucial (Lee, Houk, Ahmed, & Hughes,
2006). In our case study, the inspected DSD was detected by
karyotype analysis and confirmed by WES.

Absence or reduced expression of the *EFCAB6* gene, that
encodes DJBP, leads to a decrease in the Androgen recep-
tor (AR) transcription activity (Niki, Takahashi-Niki, Taira,
Iguchi-Ariga, & Ariga, 2003). It has been suggested that
DJBP plays a role in spermatogenesis or fertilization (Niki et
al., 2003). Besides, the DJBP protein is a part of more than
70 different binding proteins that interact with AR for its
downstream action (Gottlieb, Beitel, Nadarajah, Paliouras, &
Trifiro, 2012). Indeed, defects in the androgen receptor gene
in 46,XY individuals affect the androgen-dependent male
sexual development, leading to an androgenin sensitivity syn-
drome (AIS) (Quigley et al., 1995; Sultan et al., 2002). The

resulting phenotype exhibit sa genetic makeup of a male with
the physical traits of a female, as observed in the present case.

The co-occurrence of more than one genetic disease af-
fecting one individual and/or different members from the
same family is known as comorbidity. This phenomenon
seems to be frequently reported in highly inbred populations
as described by Romdhaneet al. (2016), where 75 disease as-
sociations were reported. While Libyan population is charac-
terized by its heterogeneous ethnic background and high rate
of consanguinity (Abudejaja et al., 1987), the report of mul-
tiple disease associations in the same individual could be ex-
pected. The main challenging consequence of comorbidity is
undoubtedly the possibility of misdiagnosis especially when
phenotypes are extremely rare and overlapping as one phe-
notype could be hidden by another (Romdhaneet al., 2016).

The initial diagnosis based on clinical and cytogenetic
findings for FA and DSD was considered as an important
starting point for further molecular approaches in order
to characterize each disease (Figure 5). During the last de-
cade, next-generation sequencing and particularly WES has
become an undeniable and a valuable tool for the identifi-
cation of genes underlying rare monogenic diseases and in
case of comorbidity as described here (Cullinane et al., 2011;
Chong al., 2015; Gilissen, Hoischen, Brunner, & Veltman,
2012; Margolin et al., 2013). Targeted gene sequencing
could be an alternative but it will not identify mutations in
hitherto unknown genes. Multiple strategies have been used
to prioritize WES variants including homozygosity mapping
which was successful in the partial elucidation of the molec-
ular etiology of our patient's phenotype (Becker et al., 2011;
Erlich et al., 2011; Gilissen et al., 2012). The autozygosity
analysis revealed the causative mutations for FA and COFS
phenotypes, whereas it has not been effective to characterize
the genetic basis of DSD traits. A candidate gene strategy for
variant filtering was adopted to identify the compound het-
erozygous mutations in the *EFCAB6* gene. This highlights
that the allelic homogeneity is not always the rule even in highly inbred population (Romdhane & Abdelhak, 2011). The challenge for clinical diagnostic laboratory is no longer a problem of detection, but of interpretation and analysis of the huge amount of generated variants in the context of the patient's phenotype. This is well-illustrated through the present case. Indeed, the presence of the *BRIP1* mutation is very challenging for genetic counsellors as they should take into consideration not only the FA risk for the descendants but also the breast cancer risk for the ascendants.

In conclusion, the present study represents the first case with the combination of three rare entities: Fanconi anemia (FA) associated with disorders of sex development (DSD) and cerebro-oculo-facial-skeletal syndrome (COFS). It also illustrates that using a combined approach, homozygosity mapping and WES represent a rapid and powerful tool that allows us to reveal pathogenic mutations in autosomal recessive inherited diseases, especially in consanguineous families. Thus, the output is considered as a support for clinical and genetic characterization of comorbid phenotypes and then contributes to a better and accurate health-care management.

## ACKNOWLEDGEMENTS

We would like to thank the patient and his family for their collaboration. This work was supported by the Tunisian Ministry of Public Health, the Tunisian Ministry of Higher Education and Scientific Research (LR16IPT05) and the E.C. Grant agreement No 295097 for FP7 project GM-NCD-Inco.

## CONFLICT OF INTEREST

Abir Ben Haj Ali, Ahlem Amouri, Marwa Sayeb, Saloua Makni, Wajih Hammami, Chokri Naouali, Hamza Dallali, Lilia Romdhane, Anu Bashamboo, Kenneth Mcelreavey, Sonia Abdelhak, Olfa Messaoud declare that they have no conflict of interest.

## AUTHOR CONTRIBUTIONS

Abir Ben Haj Ali, Wajih Hammami carried out the experimental work. Abir Ben Haj Ali drafted the manuscript. Abir Ben Haj Ali, Marwa Sayeb, Chokri Naouali, Hamza Dallali, Lilia Romdhane, Anu Bashamboo, Kenneth Mcelreavey, Olfa Messaoud analyzed the data. Ahlem Amouri, Saloua Makni, Sonia Abdelhak, Olfa Messaoud planned the experiments. Sonia Abdelhak, Olfa Messaoud finalized the manuscript.

## REFERENCES

* Abudejaja, A. H., Khan, M. A., Singh, R., Toweir, A. A., Narayanappa, M., Gupta, B. S., & Umer, S. (1987). Experience of a family clinic at

* BENGHAZI, LIBYA, and sociomedical aspects of its catchment population. *Family Practice*, 4(1), 19–26. https://doi.org/10.1093/fampra/4.1.19

* Amouri, A., Talmoudi, F., Messaoud, O., d'Enghien, C. D., Rekaya, M. B., Allegui, I., ... Meseddi, S. H. (2014). High frequency of exon 15 deletion in the FANCA gene in Tunisian patients affected with Fanconi anemia disease: implication for diagnosis. *Molecular Genetics & Genomic Medicine*, 2(2), 160–165. https://doi.org/10.1002/mgg3.55

* Auerbach, A. D. (2003). Diagnosis of Fanconi anemia by diepoxybutane analysis. *Current Protocols in Human Genetics*, 8.7.1–8.7.17. https://doi.org/10.1002/0471142905.hg0807s85

* Becker, J., Semler, O., Gilissen, C., Li, Y., Bolz, H. J., Giunta, C., ... Netzer, C. (2011). Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. *American Journal of Human Genetics*, 88(3), 362–371. https://doi.org/10.1016/j.ajhg.2011.01.015

* Bogliolo, M., Schuster, B., Stoepker, C., Derkunt, B., Su, Y., Raams, A., ... Surralles, J. (2013). Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. *American Journal of Human Genetics*, 92(5), 800–806. https://doi.org/10.1016/j.ajhg.2013.04.002

* Bouchlaka, C., Abdelhak, S., Amouri, A., Abid, H. B., Hadiji, S., Frikha, M., ... Hachicha, M. (2003). Fanconi anemia in Tunisia: High prevalence of group A and identification of new FANCA mutations. *Journal of Human Genetics*, 48(7), 352–361. https://doi.org/10.1007/s10038-003-0037-z

* Bridge, W. L., Vandenberg, C. J., Franklin, R. J., & Hiom, K. (2005). The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. *Nature Genetics*, 37(9), 953. https://doi.org/10.1038/ng1627

* Cervenka, J., Arthur, D., & Yasis, C. (1981). Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. *Pediatrics*, 67(1), 119–127.

* Cheng, Y.-C., Hsiao, F.-C., Yeh, E.-C., Lin, W.-J., Tang, C.-Y. L., Tseng, H.-C., ... Chen, Y.-T. (2012). VarioWatch: providing large-scale and comprehensive annotations on human genomic variants in the next generation sequencing era. *Nucleic Acids Research*, 40(W1), W76–W81. https://doi.org/10.1093/nar/gks397

* Chong, J. X., Buckingham, K. J., Jhangiani, S. N., Boehm, C., Sobreira, N., Smith, J. D., ... Bamshad, M. J. (2015). The genetic basis of mendelian phenotypes: discoveries, challenges, and opportunities. *American Journal of Human Genetics*, 97(2), 199–215. https://doi.org/10.1016/j.ajhg.2015.06.009

* Cullinane, A. R., Vilboux, T., O'Brien, K., Curry, J. A., Maynard, D. M., Carlson-Donohoe, H., ... Gahl, W. A. (2011). Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia. *The Journal of Investigative Dermatology*, 131(10), 2017–2025. https://doi.org/10.1038/jid.2011.157

* Drury, S., Boustred, C., Tekman, M., Stanescu, H., Kleta, R., Lench, N., ... Scott, R. H. (2014). A novel homozygous ERCC5 truncating mutation in a family with prenatal arthrogryposis—Further evidence of genotype-phenotype correlation. *American Journal of Medical Genetics Part A*, 164(7), 1777–1783. https://doi.org/10.1002/ajmg.a.36506

* Erlich, Y., Edvardson, S., Hodges, E., Zenvirt, S., Thekkat, P., Shaag, A., ... Elpeleg, O. (2011). Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. *Genome Research*, 21(5), 658–664. https://doi.org/10.1101/gr.117143.110
Faridounnia, M., Wienk, H., Kovačič, L., Folkers, G. E., Jaspers, N. G., Kaptein, R., ... Boelens, R. (2015). The Cerebro-Oculo-Facio-Skeletal (COFS) Syndrome point mutation F231L in the ERCC1 DNA repair protein causes dissociation of the ERCC1-XPF complex. *Journal of Biological Chemistry, M114*, 635169. https://doi.org/10.1074/jbc.M114.635169

Ferrer-Costa, C., Gelpí, J. L., Zamakola, L., Parraga, I., De La Cruz, X., & Orozco, M. (2005). PMUT: A web-based tool for the annotation of pathological mutations on proteins. *Bioinformatics*, 21(14), 3176-3178. https://doi.org/10.1093/bioinformatics/bti486

Gazal, S. (2014). La consanguïté à l'ère du génome haut-débit: estimations et applications. *Université Paris Sud-Paris X, OpenCheckICloseCheck*, 2014.

Ghazwani, Y., AlBalwi, M., Al-Abdulkareem, I., Al-Dress, M., Alharbi, T., Alsudairy, R., ... Alsultan, A. (2016). Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients. *Cancer Genet*, 209(4), 171-176. https://doi.org/10.1016/j.cancergen.2016.02.003

Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2012). Disease gene identification strategies for exome sequencing. *European Journal of Human Genetics*, 20(5), 490-497. https://doi.org/10.1038/ejhg.2011.258

Gottlieb, B., Beitel, L. K., Nadarajah, A., Paliouras, M., & Trifiro, M. (2012). The androgen receptor gene mutations database: 2012 update. *Human Mutation*, 33(5), 887-894. https://doi.org/10.1002/humu.22046

HadijiMseddi, S., Kammoun, L., Bellaaj, H., Ben Youssef, Y., Aissaoui, L., Torjemane, L., ... Frikha, M. (2012). Creation and report of the Tunisian Fanconi Anemia Registry (TFAR). *Archives De Pediatrie, 19*(5), 467-475. https://doi.org/10.1016/j.arcped.2012.02.017

Jaakkola, E., Mustonen, A., Olsen, P., Miettinen, S., Savuoja, T., Raams, A., ... Ignatius, J. (2010). ERCC6 founder mutation identified in Finnish patients with COFS syndrome. *Clinical Genetics*, 78(6), 541-547. https://doi.org/10.1111/j.1399-0004.2010.01424.x

Jaspers, N. G., Raams, A., Silengo, M. C., Wijgers, N., Niedernhofer, L. J., Robinson, A. R., ... Hoeijmakers, J. H. (2007). First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. *The American Journal of Human Genetics*, 80(3), 457-466. https://doi.org/10.1086/512486

Kashiyama, K., Nakazawa, Y., Pilz, D. T., Guo, C., Shimada, M., Sasaki, K., ... Ogi, T. (2013). Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xerodermapigmentosum, and Fanconi anemia. *American Journal of Human Genetics*, 92(5), 807-819. https://doi.org/10.1016/j.ajhg.2013.04.007

Kumaraswamy, E., & Shiekhattar, R. (2007). Activation of BRCA1/ BRCA2-associated helicase BACH1 is required for timely progression through S phase. *Molecular and Cellular Biology*, 27(19), 6733-6741. https://doi.org/10.1128/MCB.00961-07

Kyriakou, A., Lucas-Herald, A. K., McGowan, R., Tobias, E. S., & Ahmed, S. F. (2015). Disorders of sex development: advances in genetic diagnosis and challenges in management. *Advances in Genomics and Genetics*, 5, 165-177. https://doi.org/10.2147/AGG.S53226

Laugel, V., Dalloz, C., Durand, M., Sauvanaud, F., Kristensen, U., Vincent, M. C., ... Dollfus, H. (2010). Mutation update for the CSB/ ERCC6 andCSA/ERCC8 genes involved in Cockayne syndrome. *Human Mutation*, 31, 113-126. https://doi.org/10.1002/humu.21154

Lee, P. A., Houk, C. P., Ahmed, S. F., & Hughes, I. A. (2006). Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. *Pediatrics*, 118(2), e488-500. https://doi.org/10.1542/peds.2006-0738

Levitus, M., Waisfisz, Q., Godthelp, B. C., DeVries, Y., Hussain, S., Wiegant, W. W., ... Joenje, H. (2005). The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. *Nature Genetics*, 37(9), 934-935. https://doi.org/10.1038/ng1625

Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., ... Auerbach, A. D. (2005). The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. *Nature Genetics*, 37(9), 931-933. https://doi.org/10.1038/ng1624

Li, H., & Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. *Bioinformatics*, 25(14), 1754-1760. https://doi.org/10.1093/bioinformatics/btp324

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., ... Durbin, R. (2009). The Sequence Alignment/Map format and SAMtools. *Bioinformatics*, 25(16), 2078-2079. https://doi.org/10.1093/bioinformatics/btp352

Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., ... Cantor, S. B. (2005). BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. *Cancer Cell*, 8(3), 255-265. https://doi.org/10.1016/j.ccr.2005.08.004

Lowry, R., MacLean, R., McLean, D., & Tischler, B. (1971). Cataracts, microcephaly, kyphosis, and limited joint movement in two siblings: a new syndrome. *The Journal of Pediatrics*, 79(2), 282-284. https://doi.org/10.1016/S0002-3476(71)80114-2

Mamrak, N. E., Shimamura, A., & Howlett, N. G. (2017). Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia. *Blood Reviews*, 31(3), 93-99. https://doi.org/10.1016/j.blre.2016.10.002

Margolin, D. H., Kousi, M., Chan, Y. M., Lim, E. T., Schmahmann, J. D., Hadjivassiliou, M., ... Seminara, S. B. (2013). Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. *New England Journal of Medicine*, 368(21), 1992-2003. https://doi.org/10.1056/NEJMoa1215993

McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., ... DePristo, M. A. (2010). The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. *Genome Research*, 20(9), 1297-1303. https://doi.org/10.1101/gr.107524.110

McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R., Thormann, A., ... Cunningham, F. (2016). The ensemble variant effect predictor. *Genome Biology*, 17(1), 122. https://doi.org/10.1186/s13059-016-0974-4

McQuillan, R., Leutenegger, A.-L., Abdel-Rahman, R., Franklin, C. S., Pericic, M., Barac-Lauc, L., ... Wilson, J. F. (2008). Runs of homozygosity in European populations. *American Journal of Human Genetics*, 83(3), 359-372. https://doi.org/10.1016/j.ajhg.2008.08.007

Meira, L. B., Graham, J. M., Greenberg, C. R., Busch, D. B., Doughty, A. T., Ziffer, D. W., ... Friedberg, E. C. (2000). Manitoba aboriginal kindred with original cerebro-oculo-facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. *The American Journal of Human Genetics*, 66(4), 1221-1228. https://doi.org/10.1086/302867

Miller, S., Dykes, D., & Polesky, H. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. *Nucleic Acids Research*, 16(3), 1215. https://doi.org/10.1093/nar/16.3.1215
Nouspikel, T. (2009). Nucleotide excision repair: variations on versatility. *Cellular and Molecular Life Sciences*, **66**, 994–1009.

Ng, P. C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. *Nucleic Acids Research*, **31**(13), 3812–3814. https://doi.org/10.1007/s00018-009-8737-y

Niki, T., Takahashi-Niki, K., Taira, T., Iguchi-Ariga, S. M., & Ariga, H. (2003). DJBP: A novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. *Molecular Cancer Research*, **1**(4), 247–261.

Powell, C., Meira, L., & Friedberg, E. (2000). Mutation in the CSB gene in a patient with cerebro-oculo-facio-skeletal syndrome. *Genetics in Medicine*, **2**(1), 85. https://doi.org/10.1097/00125817-20000 1000-00121

Preus, M., & Fraser, F. C. (1974). The cerebro-oculo-facio-skeletal syndrome. *Clinical Genetics*, **5**(4), 294–297. https://doi.org/10.1111/j.1399-0004.1974.tb01696.x

Quigley, C. A., DeBellis, A., Marschke, K. B., el-Awady, M. K., Wilson, E. M., & French, F. S. (1995). Androgen receptor defects: Historical, clinical, and molecular perspectives. *Endocrine Reviews*, **16**(3), 271–321. https://doi.org/10.1210/edrv-16-3-271

Reese, M. G., Eeckman, F. H., Kulp, D., & Haussler, D. (1997). Improved splice site detection in Genie. *Journal of Computational Biology*, **4**(3), 311–323. https://doi.org/10.1089/cmb.1997.4.311

Romdhane, L., & Abdelhak, S. (2011). Genetic diseases in the Tunisian population. *American Journal of Medical Genetics. Part A*, **155A**(1), 238–267. https://doi.org/10.1002/ajmg.a.33771

Romdhane, L., Messaoud, O., Bouyacoub, Y., Kerkeni, E., Naouali, C., Cherif Ben Abdallah, L., ... Chabchoub, I. (2016). Comorbidity in the Tunisian population. *Clinical Genetics*, **89**(3), 312–319. https://doi.org/10.1111/cge.12616

Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., ... Spanova, K. (2006). Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. *Nature Genetics*, **38**(11), 1239. https://doi.org/10.1038/ng1902

Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S., ... Cooper, D. N. (2003). Human gene mutation database (HGMD®): 2003 update. *Human Mutation*, **21**(6), 577–581. https://doi.org/10.1002/humu.10212

Sultan, C., Lumbroso, S., Paris, F., Jeandel, C., Terouanne, B., Belon, C., ... Nicolas, J. C. (2002). Disorders of androgen action.

Seminars in Reproductive Medicine, 20(3), 217–228. https://doi.org/10.1055/s-2002-35386

Sunyaev, S., Ramensky, V., Koch, I., Lathe, W. III, Kondrashov, A. S., & Bork, P. (2001). Prediction of deleterious human alleles. *Human Molecular Genetics*, **10**(6), 591–597. https://doi.org/10.1093/hmg/10.6.591

Talmoudi, F., Kilani, O., Ayed, W., Ben Halim, N., Mellouli, F., Torjmane, L., ... Amouri, A. (2013). Differentiation of Fanconi anemia and aplastic anemia using mitomycin C test in Tunisia. *CR Biol*, **336**(1), 29–33. https://doi.org/10.1016/j.crvi.2013.02.001

Tamary, H., Bar-Yam, R., Shalmon, L., Rachavi, G., Krostichevsky, M., Elhasid, R., ... Zaizov, R. (2000). Fanconianaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients. *British Journal of Haematology*, **111**(1), 338–343. https://doi.org/10.1111/j.1365-2141.2000.02323.x

Tavtigian, S. V., Deffenbaugh, A. M., Yin, L., Judkins, T., Scholl, T., Samollow, P. B., ... Thomas, A. (2006). Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. *Journal of Medical Genetics*, **43**(4),295–305, https://doi.org/10.1136/jmg.2005.033878

Teebi, A. S. (1994). Autosomal recessive disorders among Arabs: an overview from Kuwait. *Journal of Medical Genetics*, **31**(3), 224–233. https://doi.org/10.1136/jmg.31.3.224

Temtamy, S. A., Ismail, S. R., ElBeshlawy, A. M., Mohamed, A. M., Kotb, S. M., & Eid, M. M. (2007). Fanconi Anemia: Cytogenetic and clinical studies on a group of Fanconi anemia patients in egypt. *Egypt Haematology*, **10**, 61–67.

Walsh, T., & King, M.-C. (2007). Ten genes for inherited breast cancer. *Cancer Cell*, **11**(2), 103–105. https://doi.org/10.1016/j.ccr.2007.01.010

**How to cite this article:** Ben Haj Ali A, Amouri A, Sayeb M, et al. Cytogenetic and molecular diagnosis of Fanconi anemia revealed two hidden phenotypes: Disorder of sex development and cerebro-oculo-facio-skeletal syndrome. *Mol Genet Genomic Med.* 2019;7:e694. https://doi.org/10.1002/mgg3.694